Here, silencing of RNF20 led to increased proliferation and migration in basal-like breast tumours, likely via upregulation of inflammatory cytokines, while silencing of RNF20 in luminal breast cancer cells decreased proliferation and migration, compromising transcription of the estrogen receptor [84]. Here, RNF20 is linked to breast cancer.